Mouse models of fragile X-associated tremor ataxia
- PMID: 19574928
- PMCID: PMC2787904
- DOI: 10.2310/JIM.0b013e3181af59d6
Mouse models of fragile X-associated tremor ataxia
Abstract
Objective: To describe the development of mouse models of fragile X-associated tremor/ataxia (FXTAS) and the behavioral, histological and molecular characteristics of these mice.
Method: This paper compares the pathophysiology and neuropsychological features of FXTAS in humans to the major mouse models of FXTAS. Specifically, the development of a transgenic mouse line carrying an expanded CGG trinucleotide repeat in the 5'-untranslated region (5'-UTR) of the Fmr1 gene is described along with a description of the characteristic intranuclear ubiquitin-positive inclusions and the behavioral sequella observed in these mice.
Results: CGG KI mice model many of the important features of FXTAS, although some aspects are not well modeled in mice. Aspects of FXTAS that are modeled well include elevated levels of Fmr1 mRNA, reduced levels of Fmrp, the presence of intranuclear inclusions that develop with age and show similar distributions within neurons, and neuropsychological and cognitive deficits, including poor motor function, impaired memory and evidence of increased anxiety. Features of FXTAS that are not well modeled in these mice include intentional tremors that are observed in some FXTAS patients but have not been reported in CGG KI mice. In addition, although intranuclear inclusions in astrocytes are very prominent in FXTAS, there are relatively few observed in CGG KI mice. A number of additional features of FXTAS have not been systematically examined in mouse models yet, including white matter disease, hyperintensities in T2-weighted magnetic resonance imaging, and brain atrophy, although these are currently under investigation in our laboratories.
Conclusions: The available mouse model has provided valuable insights into the molecular biology and pathophysiology of FXTAS and will be particularly useful for developing and testing new therapeutic treatments in the future.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4525/2787904/f474d90011a2/nihms139658f1.gif)
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4525/2787904/c4429bf2d640/nihms139658f2.gif)
Similar articles
-
Astroglial-targeted expression of the fragile X CGG repeat premutation in mice yields RAN translation, motor deficits and possible evidence for cell-to-cell propagation of FXTAS pathology.Acta Neuropathol Commun. 2019 Feb 26;7(1):27. doi: 10.1186/s40478-019-0677-7. Acta Neuropathol Commun. 2019. PMID: 30808398 Free PMC article.
-
Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.Hum Reprod. 2016 Jan;31(1):158-68. doi: 10.1093/humrep/dev280. Epub 2015 Nov 3. Hum Reprod. 2016. PMID: 26537920 Free PMC article.
-
What has been learned from mouse models of the Fragile X Premutation and Fragile X-associated tremor/ataxia syndrome?Clin Neuropsychol. 2016 Aug;30(6):960-72. doi: 10.1080/13854046.2016.1158254. Epub 2016 Jun 29. Clin Neuropsychol. 2016. PMID: 27355912 Free PMC article. Review.
-
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS).Brain. 2006 Jan;129(Pt 1):243-55. doi: 10.1093/brain/awh683. Epub 2005 Dec 5. Brain. 2006. PMID: 16332642
-
Potential pathogenic mechanisms underlying Fragile X Tremor Ataxia Syndrome: RAN translation and/or RNA gain-of-function?Eur J Med Genet. 2018 Nov;61(11):674-679. doi: 10.1016/j.ejmg.2017.11.001. Epub 2017 Dec 6. Eur J Med Genet. 2018. PMID: 29223504 Review.
Cited by
-
Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons.Eur J Neurosci. 2020 May;51(10):2143-2157. doi: 10.1111/ejn.14660. Epub 2020 Feb 4. Eur J Neurosci. 2020. PMID: 31880363 Free PMC article.
-
Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.Mol Autism. 2010 Sep 21;1(1):12. doi: 10.1186/2040-2392-1-12. Mol Autism. 2010. PMID: 20858229 Free PMC article.
-
Advances in understanding the molecular basis of FXTAS.Hum Mol Genet. 2010 Apr 15;19(R1):R83-9. doi: 10.1093/hmg/ddq166. Epub 2010 Apr 29. Hum Mol Genet. 2010. PMID: 20430935 Free PMC article. Review.
-
Immune dysregulation as a cause of autoinflammation in fragile X premutation carriers: link between FMRI CGG repeat number and decreased cytokine responses.PLoS One. 2014 Apr 9;9(4):e94475. doi: 10.1371/journal.pone.0094475. eCollection 2014. PLoS One. 2014. PMID: 24718368 Free PMC article.
-
In silico, in vitro, and in vivo Approaches to Identify Molecular Players in Fragile X Tremor and Ataxia Syndrome.Front Mol Biosci. 2020 Mar 11;7:31. doi: 10.3389/fmolb.2020.00031. eCollection 2020. Front Mol Biosci. 2020. PMID: 32219099 Free PMC article. Review.
References
-
- Hagerman RJ, Ono MY, Hagerman PJ. Recent advances in fragile X: a model for autism and neurodegeneration. Curr Opin Psychiatry. 2005;18:490–496. - PubMed
-
- Hagerman PJ, Hagerman RJ. Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) Ment Retard Dev Disabil Res Rev. 2004;10:25–30. - PubMed
-
- Bontekoe CJ, de Graaff E, Nieuwenhuizen IM, et al. FMR1 premutation allele (CGG)81 is stable in mice. Eur J Hum Genet. 1997;5:293–298. - PubMed
-
- Willemsen R, Hoogeveen-Westerveld M, Reis S, et al. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum Mol Genet. 2003;12:949–959. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical